These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 19966072)
1. Pharmacist-led group medical appointment model in type 2 diabetes. Taveira TH; Friedmann PD; Cohen LB; Dooley AG; Khatana SA; Pirraglia PA; Wu WC Diabetes Educ; 2010; 36(1):109-17. PubMed ID: 19966072 [TBL] [Abstract][Full Text] [Related]
2. Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Taveira TH; Dooley AG; Cohen LB; Khatana SA; Wu WC Ann Pharmacother; 2011 Nov; 45(11):1346-55. PubMed ID: 22028418 [TBL] [Abstract][Full Text] [Related]
3. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Cohen LB; Taveira TH; Khatana SA; Dooley AG; Pirraglia PA; Wu WC Diabetes Educ; 2011; 37(6):801-12. PubMed ID: 22021025 [TBL] [Abstract][Full Text] [Related]
4. Multidisciplinary group behavioral and pharmacologic intervention for cardiac risk reduction in diabetes: a pilot study. Martin OJ; Wu WC; Taveira TH; Eaton CB; Sharma SC Diabetes Educ; 2007; 33(1):118-27. PubMed ID: 17272798 [TBL] [Abstract][Full Text] [Related]
5. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. Edelman D; Fredrickson SK; Melnyk SD; Coffman CJ; Jeffreys AS; Datta S; Jackson GL; Harris AC; Hamilton NS; Stewart H; Stein J; Weinberger M Ann Intern Med; 2010 Jun; 152(11):689-96. PubMed ID: 20513826 [TBL] [Abstract][Full Text] [Related]
6. Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial. Wu WC; Taveira TH; Jeffery S; Jiang L; Tokuda L; Musial J; Cohen LB; Uhrle F PLoS One; 2018; 13(4):e0195898. PubMed ID: 29672567 [TBL] [Abstract][Full Text] [Related]
7. Pharmacists' impact on improving outcomes in patients with type 2 diabetes mellitus. Pepper MJ; Mallory N; Coker TN; Chaki A; Sando KR Diabetes Educ; 2012; 38(3):409-16. PubMed ID: 22523190 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Addition of Pharmacist Management to a Medication Assistance Program in Patients with Hypertension and Diabetes Resistant to Usual Care. Smith AM; Hamann GL; Campbell JD; Sprabery LR J Pharm Pract; 2022 Aug; 35(4):606-611. PubMed ID: 33739190 [TBL] [Abstract][Full Text] [Related]
9. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Rothman RL; Malone R; Bryant B; Shintani AK; Crigler B; Dewalt DA; Dittus RS; Weinberger M; Pignone MP Am J Med; 2005 Mar; 118(3):276-84. PubMed ID: 15745726 [TBL] [Abstract][Full Text] [Related]
10. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W; J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175 [TBL] [Abstract][Full Text] [Related]
11. A randomized controlled study to evaluate the effect of pharmacist-led educational intervention on glycemic control, self-care activities and disease knowledge among type 2 diabetes patients: A consort compliant study protocol. Bukhsh A; Nawaz MS; Ahmed HS; Khan TM Medicine (Baltimore); 2018 Mar; 97(12):e9847. PubMed ID: 29561461 [TBL] [Abstract][Full Text] [Related]
12. The effect of nurse-led diabetes self-management education on glycosylated hemoglobin and cardiovascular risk factors: a meta-analysis. Tshiananga JK; Kocher S; Weber C; Erny-Albrecht K; Berndt K; Neeser K Diabetes Educ; 2012; 38(1):108-23. PubMed ID: 22116473 [TBL] [Abstract][Full Text] [Related]
13. Effect of a community pharmacist-delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Jahangard-Rafsanjani Z; Sarayani A; Nosrati M; Saadat N; Rashidian A; Hadjibabaie M; Ashouri A; Radfar M; Javadi M; Gholami K Diabetes Educ; 2015 Feb; 41(1):127-35. PubMed ID: 25420946 [TBL] [Abstract][Full Text] [Related]
14. Pharmacist-led telehealth disease management program for patients with diabetes and depression. Cohen LB; Taveira TH; Wu WC; Pirraglia PA J Telemed Telecare; 2020 Jun; 26(5):294-302. PubMed ID: 30691328 [TBL] [Abstract][Full Text] [Related]
15. Impact of pharmacist-led care on glycaemic control of patients with uncontrolled type 2 diabetes: a randomised controlled trial in Nigeria. David EA; Soremekun RO; Abah IO; Aderemi-Williams RI Pharm Pract (Granada); 2021; 19(3):2402. PubMed ID: 34457094 [TBL] [Abstract][Full Text] [Related]
16. Pharmacist-provided diabetes management and education via a telemonitoring program. Shane-McWhorter L; McAdam-Marx C; Lenert L; Petersen M; Woolsey S; Coursey JM; Whittaker TC; Hyer C; LaMarche D; Carroll P; Chuy L J Am Pharm Assoc (2003); 2015; 55(5):516-26. PubMed ID: 26359961 [TBL] [Abstract][Full Text] [Related]
17. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. Suppapitiporn S; Chindavijak B; Onsanit S J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S134-41. PubMed ID: 16623018 [TBL] [Abstract][Full Text] [Related]
18. Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial. Ladhani NN; Majumdar SR; Johnson JA; Tsuyuki RT; Lewanczuk RZ; Spooner R; Simpson SH Diabet Med; 2012 Nov; 29(11):1433-9. PubMed ID: 22486226 [TBL] [Abstract][Full Text] [Related]